EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 0.1067
March 31, 2026 0.1126
December 31, 2025 -0.5554
September 30, 2025 -0.0684
June 30, 2025 0.0222
March 31, 2025 0.1353
December 31, 2024 -0.0162
September 30, 2024 0.7314
June 30, 2024 -0.1012
March 31, 2024 0.0645
December 31, 2023 -0.2861
September 30, 2023 -2.224
June 30, 2023 -0.1969
March 31, 2023 0.209
December 31, 2022 -0.1105
September 30, 2022 -0.1331
June 30, 2022 -0.0205
Date Value
March 31, 2022 0.1036
December 31, 2021 -0.2134
September 30, 2021 -0.2134
June 30, 2021 -0.431
March 31, 2021 -0.1253
December 31, 2020 -0.6639
September 30, 2020 -0.292
June 30, 2020 -0.1288
March 31, 2020 -0.1216
December 31, 2019 -0.0255
September 30, 2019 0.0268
June 30, 2019 0.0978
March 31, 2019 0.0861
December 31, 2018 0.0449
September 30, 2018 0.1647
June 30, 2018 -0.1718
March 31, 2018 0.1988

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 1.654
Eli Lilly & Co. 7.939
ANI Pharmaceuticals, Inc. 1.052
EyePoint, Inc. -1.092
Amylyx Pharmaceuticals, Inc. -0.3905